Trial Profile
Intensified program including Bendamustine followed by PBSC mobilization and high dose therapy and autograft for patients with relapsed or resistant CD 20+ Follicular Non Hodgkin Lymphoma: a multicenter, pivotal GITIL study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Oxaliplatin
- Indications Follicular lymphoma
- Focus Adverse reactions
- Acronyms GITIL
- 20 Jul 2011 New trial record